JNJ
Johnson & Johnson
$256.79
▲ +0.83%
+$2.13
NYSE · Healthcare · Drug Manufacturers - General
Johnson & Johnson
JNJ · NYSE · Healthcare · Drug Manufacturers - General
$256.79
▲ +0.83% · +$2.13 today
fundamentals54 /100 vs peers
weak
Revenue growth (TTM)7.9
below average pace
EPS growth (TTM)-3.6
weak pace
EPS forecast (5Y)9.2
average pace
EPS next year10.3
solid pace
EPS growth (Q/Q)-52.8
weak pace
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| JNJJohnson & Johnson | $618.14B | 29.8 | +7.9% | 54 |
| INDVIndivior | $4.59B | 19.1 | -0.3% | 84 |
| LLYEli Lilly and Company | $1.14T | 43.5 | +47.4% | 83 |
| DXCMDexcom | $28.11B | 31.2 | +16.1% | 76 |
| GMEDGlobus Medical | $10.85B | 18.6 | +23.5% | 76 |
